Over 1,000 clients among top pharmaceutical companies worldwide, CHEMO holds a position of leading company in industry, developing and manufacturing added-value active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs), both for human and animal health, in all mayor therapeutics (Cardiovascular, Gastroenterology, Central Nervous System, Anti-infective, Respiratory, Women`s Healthcare, Endocrinology, Dermatology and Urology).
CHEMO`s own manufacturing network comprises 9 state-of-the-art facilities, 4 chemical (Spain, Italy, Argentina, India) and 5 pharmaceutical sites in Spain, with cutting-edge technologies, highly qualified professionals, high safety standards, and most up-to-date equipments to perform a wide variety of chemical reactions and to produce added-value medicines, in a variety of dosage forms. The company is subject to GMP (Good Manufacturing Practice) compliance and the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA), and is periodically inspected by leading pharmaceutical companies.